Rifampin-Induced Selective Serotonin Reuptake Inhibitor Withdrawal Syndrome in a Patient Treated With Sertraline
- 1 February 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 20 (1) , 109-110
- https://doi.org/10.1097/00004714-200002000-00023
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Rifampin reduces plasma concentrations and effects of zolpidem*Clinical Pharmacology & Therapeutics, 1997
- Update on rifampin drug interactions, IIIArchives of internal medicine (1960), 1997
- Induction of CYP3A isoforms in cultured precisioncut human liver slicesXenobiotica, 1997
- Triazolam is ineffective in patients taking rifampinClinical Pharmacology & Therapeutics, 1997
- Dr. Nemeroff and Colleagues ReplyAmerican Journal of Psychiatry, 1996
- Rifampin drastically reduces plasma concentrations and effects of oral midazolamPublished by Wiley ,1996
- The Emerging Role of Cytochrome P450 3A in PsychopharmacologyJournal of Clinical Psychopharmacology, 1995
- The influence of rifampin treatment on caffeine clearance in healthy manJournal of Hepatology, 1995
- Pharmacokinetic interaction between rifampin and zidovudineAntimicrobial Agents and Chemotherapy, 1993
- Clinical Implications of the Pharmacology of SertralineInternational Clinical Psychopharmacology, 1991